CG Oncology, Inc. Common stock (CGON) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CGON. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 218 institutions reported holding CGON, with 93.7 million shares worth $6.7 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| T. Rowe Price | 10,421,909 | $740M | INCREASED |
| Rtw Investments | 8,514,590 | $605M | INCREASED |
| Vanguard | 7,406,739 | $526M | INCREASED |
| Decheng Capital | 6,371,669 | $453M | UNCHANGED |
| BlackRock | 6,256,288 | $445M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Isabel Kalofonos (Chief Commercial Officer) | AWARD | 92,000 | $6M | 2026-10-15 |
| Leonard E Post (Director) | EXERCISE | 1,000 | $600 | 2026-10-15 |
| Leonard E Post (Director) | SELL | 500 | $31K | 2026-10-15 |
| Leonard E Post (Director) | SELL | 500 | $31K | 2026-10-15 |
| Leonard E Post (Director) | EXERCISE | 1,000 | $600 | 2026-10-15 |
Full institutional holdings, insider history, and congressional trades for CG Oncology, Inc. Common stock on SentiSense.